Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
The latest announcement is out from Fisher & Paykel Healthcare Corporation Limited ( (FSPKF) ).
Fisher & Paykel Healthcare Corporation Limited reported a strong financial performance for the first half of the 2026 fiscal year, with a 14% increase in operating revenue to $1.09 billion and a 39% rise in net profit after tax to $213 million. The company experienced significant growth across its Hospital and Homecare product groups, driven by increased sales of humidification products and obstructive sleep apnea masks. Despite challenges such as US tariffs, the company improved its gross margin and increased its interim dividend. The positive results reflect the company’s robust market positioning and commitment to innovation, with a continued focus on efficiency improvements and new product development.
More about Fisher & Paykel Healthcare Corporation Limited
Fisher & Paykel Healthcare is a leading designer, manufacturer, and marketer of products and systems for use in acute and chronic respiratory care, surgery, and the treatment of obstructive sleep apnea. Their products are sold in more than 120 countries worldwide.
Find detailed analytics on FSPKF stock on TipRanks’ Stock Analysis page.